Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

310 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 7: PD-L1 Expression in Liquid Biopsy.
Palicelli A, Bonacini M, Croci S, Bisagni A, Zanetti E, De Biase D, Sanguedolce F, Ragazzi M, Zanelli M, Chaux A, Cañete-Portillo S, Bonasoni MP, Ascani S, De Leo A, Gandhi J, Tafuni A, Melli B. Palicelli A, et al. Among authors: de biase d, de leo a. J Pers Med. 2021 Dec 6;11(12):1312. doi: 10.3390/jpm11121312. J Pers Med. 2021. PMID: 34945784 Free PMC article. Review.
High-sensitivity BRAF mutation analysis: BRAF V600E is acquired early during tumor development but is heterogeneously distributed in a subset of papillary thyroid carcinomas.
de Biase D, Cesari V, Visani M, Casadei GP, Cremonini N, Gandolfi G, Sancisi V, Ragazzi M, Pession A, Ciarrocchi A, Tallini G. de Biase D, et al. J Clin Endocrinol Metab. 2014 Aug;99(8):E1530-8. doi: 10.1210/jc.2013-4389. Epub 2014 Apr 29. J Clin Endocrinol Metab. 2014. PMID: 24780046
TERT Promoter Mutations in Papillary Thyroid Microcarcinomas.
de Biase D, Gandolfi G, Ragazzi M, Eszlinger M, Sancisi V, Gugnoni M, Visani M, Pession A, Casadei G, Durante C, Costante G, Bruno R, Torlontano M, Paschke R, Filetti S, Piana S, Frasoldati A, Tallini G, Ciarrocchi A. de Biase D, et al. Thyroid. 2015 Sep;25(9):1013-9. doi: 10.1089/thy.2015.0101. Epub 2015 Aug 5. Thyroid. 2015. PMID: 26148423
Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4.
Masetti M, Acquaviva G, Visani M, Tallini G, Fornelli A, Ragazzi M, Vasuri F, Grifoni D, Di Giacomo S, Fiorino S, Lombardi R, Tuminati D, Ravaioli M, Fabbri C, Bacchi-Reggiani ML, Pession A, Jovine E, de Biase D. Masetti M, et al. Among authors: de biase d. Cancer Biomark. 2018 Feb 6;21(2):323-334. doi: 10.3233/CBM-170464. Cancer Biomark. 2018. PMID: 29103024
Genome-wide profiling identifies the THYT1 signature as a distinctive feature of widely metastatic Papillary Thyroid Carcinomas.
Gandolfi G, Ragazzi M, de Biase D, Visani M, Zanetti E, Torricelli F, Sancisi V, Gugnoni M, Manzotti G, Braglia L, Cavuto S, Merlo DF, Tallini G, Frasoldati A, Piana S, Ciarrocchi A. Gandolfi G, et al. Among authors: de biase d. Oncotarget. 2017 Dec 1;9(2):1813-1825. doi: 10.18632/oncotarget.22805. eCollection 2018 Jan 5. Oncotarget. 2017. PMID: 29416733 Free PMC article.
Not the same thing: metastatic PTCs have a different background than ATCs.
de Biase D, Torricelli F, Ragazzi M, Donati B, Kuhn E, Visani M, Acquaviva G, Pession A, Tallini G, Piana S, Ciarrocchi A. de Biase D, et al. Endocr Connect. 2018 Dec;7(12):1370-1379. doi: 10.1530/EC-18-0386. Endocr Connect. 2018. PMID: 30400028 Free PMC article.
310 results